Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Asset Writedowns and Impairment (2018 - 2019)

Prestige Consumer Healthcare (PBH) has 2 years of Asset Writedowns and Impairment data on record, last reported at $229.5 million in Q1 2019.

  • For Q1 2019, Asset Writedowns and Impairment rose 129.64% year-over-year to $229.5 million; the TTM value through Mar 2019 reached $229.5 million, up 129.64%, while the annual FY2025 figure was $12.5 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached $229.5 million in Q1 2019 per PBH's latest filing, up from $99.9 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $229.5 million in Q1 2019 and bottomed at $99.9 million in Q1 2018.